OLIPASS Corporation (KOSDAQ:244460)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,651.00
-267.00 (-13.92%)
At close: Apr 7, 2025

OLIPASS Revenue

OLIPASS had revenue of 1.17B KRW in the quarter ending June 30, 2026, a decrease of -35.64%. This brings the company's total for the last twelve months to 5.25B, up 190.70% year-over-year. In the year 2022, OLIPASS had annual revenue of 2.30B with 169.56% growth. That makes OLIPASS the 40,708th largest company in the world by revenue and 2,517th in South Korea.

Revenue (ttm)
5.25B
Revenue Growth
+190.70%
P/S Ratio
1.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20222.30B1.44B169.56%
Dec 31, 2021851.78M-2.01B-70.23%
Dec 31, 20202.86B1.16B67.75%
Dec 31, 20191.71B1.22B249.26%
Dec 31, 2018488.26M376.33M336.22%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
NGeneBio41.80B
ADBiotech12.57B
MOA Life Plus10.46B
Genotech7.28B
Poongjeon Pharmacy CO.,LTD.1.54B
Angiolab702.62M
Progen450.00M
Epibiotech449.62M
Revenue Rankings